- $3.33bn
- $3.95bn
- $2.51bn
- 82
- 51
- 90
- 87
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,131 | 1,752 | 2,301 | 2,606 | 2,512 |
Cost of Revenue | |||||
Gross Profit | 797 | 576 | 780 | 926 | 957 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,924 | 1,602 | 2,043 | 2,250 | 2,195 |
Operating Profit | 207 | 150 | 258 | 357 | 318 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 152 | 90.8 | 227 | 317 | 286 |
Provision for Income Taxes | |||||
Net Income After Taxes | 110 | 70.7 | 199 | 268 | 243 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -377 | -55.2 | 63.9 | 255 | 243 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -395 | -55.2 | 63.9 | 255 | 243 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.62 | 1.73 | 4.92 | 5.87 | 6.42 |
Dividends per Share |